Simplex Trading’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-94,800
| Closed | -$945K | – | 9509 |
|
|
2025
Q2 | $945K | Buy |
94,800
+44,400
| +88% | +$358K | ﹤0.01% | 2840 |
|
|
2025
Q1 | $300K | Sell |
50,400
-187,600
| -79% | -$1.38M | ﹤0.01% | 3917 |
|
|
2024
Q4 | $1.83M | Sell |
238,000
-36,200
| -13% | -$311K | ﹤0.01% | 2271 |
|
|
2024
Q3 | $2.8M | Buy |
274,200
+273,500
| +39,071% | +$4.17M | ﹤0.01% | 1981 |
|
|
2024
Q2 | $10K | Sell |
700
-37,900
| -98% | -$543K | ﹤0.01% | 7424 |
|
|
2024
Q1 | $526K | Sell |
38,600
-6,800
| -15% | -$74.1K | ﹤0.01% | 3811 |
|
|
2023
Q4 | $497K | Sell |
45,400
-17,300
| -28% | -$171K | ﹤0.01% | 3711 |
|
|
2023
Q3 | $686K | Buy |
62,700
+58,500
| +1,393% | +$748K | ﹤0.01% | 3051 |
|
|
2023
Q2 | $55K | Buy |
4,200
+3,100
| +282% | +$44.2K | ﹤0.01% | 5749 |
|
|
2023
Q1 | $14K | Buy |
+1,100
| New | +$19.7K | ﹤0.01% | 7250 |
|
|
2022
Q4 | – | Sell |
-500
| Closed | -$9K | – | 9759 |
|
|
2022
Q3 | $9K | Sell |
500
-15,000
| -97% | -$346K | ﹤0.01% | 8327 |
|
|
2022
Q2 | $319K | Buy |
15,500
+14,600
| +1,622% | +$346K | ﹤0.01% | 4023 |
|
|
2022
Q1 | $28K | Buy |
+900
| New | +$32.7K | ﹤0.01% | 7844 |
|
Other funds holding ITOS
Simplex Trading's ITOS Position: Q3 2025 in Review
Simplex Trading sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 103,212 shares — an estimated $1.03M sold.
Simplex Trading first reported a position in ITOS in Q2 2022 and held it in 9 quarters. The position peaked at $1.03M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.
- Simplex Trading reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 103,212 iTeos Therapeutics shares in Q3 2025, an estimated $1.03M.
- Simplex Trading first reported a position in iTeos Therapeutics in Q2 2022 and held it in 9 quarters.
- Simplex Trading's iTeos Therapeutics position peaked at $1.03M in Q2 2025.
- 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.